Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Lung Neoplasms 8 Colorectal Neoplasms 6 Hematologic Neoplasms 5 Prostatic Neoplasms 4 Hodgkin Disease 4 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Motor Activity 3 Pancreatic Neoplasms 2 Obesity 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Hematopoietic and Lymphoid System Neoplasm 2 Gastrointestinal Diseases 2 Cardiotoxicity 2 Urinary Bladder Neoplasms 1 Trastuzumab Cardiotoxicity 1 Stress Disorders, Post-Traumatic 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Sedentary Behavior 1 Sarcopenia 1 Radiation Pneumonitis 1 Radiation Fibrosis Syndrome 1 Polycystic Ovary Syndrome 1 Pelvic Neoplasms 1 Pathologically Proven Gastrointestinal Malignancy 1 Oropharyngeal Neoplasms 1

Interventions

pembrolizumab 29 avelumab 21 Nivolumab 20 Ipilimumab 10 Radiotherapy 9 Cyclophosphamide 9 atezolizumab 8 cemiplimab 7 fludarabine 6 Specimen Handling 6 durvalumab 5 aldesleukin 5 Radiation 5 Magnetic Resonance Spectroscopy 5 Interleukin-2 5 Biopsy 5 talimogene laherparepvec 4 ALT-803 4 poly ICLC 3 Radiosurgery 3 Etoposide 3 Cisplatin 3 Carboplatin 3 CTLA-4 Antigen 3 Bevacizumab 3 prednylidene 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 domatinostat 2 deltacortene 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Exercise Test × Clear all

NCT06008977 2026-03-25

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Active not recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡